Norwood Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$218K Sell
7,843
-10,573
-57% -$293K 0.31% 68
2023
Q4
$530K Sell
18,416
-300
-2% -$9.07K 0.8% 28
2023
Q3
$621K Sell
18,716
-85
-0.5% -$3.01K 1% 25
2023
Q2
$690K Buy
18,801
+2,718
+17% +$106K 1.03% 24
2023
Q1
$656K Buy
16,083
+1,795
+13% +$77.5K 1.04% 24
2022
Q4
$732K Buy
14,288
+150
+1% +$7.19K 1.15% 20
2022
Q3
$618K Buy
14,138
+100
+0.7% +$4.86K 1.09% 22
2022
Q2
$736K Hold
14,038
1.25% 19
2022
Q1
$727K Buy
14,038
+750
+6% +$38.9K 1.06% 23
2021
Q4
$784K Buy
+13,288
New +$658K 1.09% 21

Other funds holding PFE

Norwood Financial's PFE Position: Q1 2024 in Review

Norwood Financial reduced its Pfizer (PFE) stake by 57% in Q1 2024, selling an estimated $293K and leaving 7,843 shares worth $218K. The position accounts for 0.31% of the portfolio, ranked #68.

Norwood Financial first reported a position in PFE in Q4 2021 and has held it in 10 quarters since. The position peaked at $784K in Q4 2021. 2,875 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

  • Norwood Financial held 7,843 shares of Pfizer worth $218K as of Q1 2024.
  • Norwood Financial sold 10,573 Pfizer shares in Q1 2024, an estimated $293K.
  • Pfizer made up 0.31% of Norwood Financial's portfolio in Q1 2024, its #68 holding.
  • Norwood Financial first reported a position in Pfizer in Q4 2021 and has held it in 10 quarters since.
  • Norwood Financial's Pfizer position peaked at $784K in Q4 2021.
  • 2,875 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Norwood Financial's 13F filing for Q1 2024, filed 16 Apr 2024.